Difference between revisions of "Sahebjam S, et al. Br. J. Cancer (2013) cited as Ref 589 in DOI: 10.1038/s41392-020-0110-5 (Q9852)"
Jump to navigation
Jump to search
(Created claim: First Author string (P149): Sahebjam S, #quickstatements; #temporary_batch_1589996169159) |
(Created claim: Page(s) (P105): 943-949, #quickstatements; #temporary_batch_1590074839150) |
||||||||||||||
| (6 intermediate revisions by the same user not shown) | |||||||||||||||
| Property / DOI Identifier | |||||||||||||||
| + | |||||||||||||||
| Property / DOI Identifier: 10.1038/bjc.2013.380 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / PubMed ID | |||||||||||||||
| + | |||||||||||||||
| Property / PubMed ID: 23868004 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Publication Date | |||||||||||||||
| + | 2013
| ||||||||||||||
| Property / Publication Date: 2013 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Published In Name String | |||||||||||||||
| + | Br. J. Cancer | ||||||||||||||
| Property / Published In Name String: Br. J. Cancer / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Volume | |||||||||||||||
| + | 109 | ||||||||||||||
| Property / Volume: 109 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / title | |||||||||||||||
| + | A phase I study of the combination of ro4929097 and cediranib in patients with advanced solid tumours (PJC-004/NCI 8503) (English) | ||||||||||||||
| Property / title: A phase I study of the combination of ro4929097 and cediranib in patients with advanced solid tumours (PJC-004/NCI 8503) (English) / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Page(s) | |||||||||||||||
| + | 943-949 | ||||||||||||||
| Property / Page(s): 943-949 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
Latest revision as of 15:46, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Sahebjam S, et al. Br. J. Cancer (2013) cited as Ref 589 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Sahebjam S
0 references
2013
0 references
Br. J. Cancer
0 references
109
0 references
A phase I study of the combination of ro4929097 and cediranib in patients with advanced solid tumours (PJC-004/NCI 8503) (English)
0 references
943-949
0 references
